PCNA and familial pancreatic carcinoma: Tumor suppressive effects have, for instance, been reported in pancreatic cancer cell lines, where treatment with exogenous biglycan leads to an up-regulation of cyclin-dependent kinase inhibitor p27, down-regulation of Cyclin A and PCNA (proliferating cell nuclear antigen), and cell cycle arrest (204) (Figure 2).